Dr. Spencer Cranston Payne, MD

Dr. Payne practices at UVA University Medical Center in Charlottesville, Virginia.

Dr. Payne's NPI, 1679564777, was assigned on October 31, 2005. Dr. Payne graduated from Renaissance School of Medicine at Stony Brook University in 2001. Dr. Payne holds Virginia license 0101241639.

Dr. Payne's primary practice is UVA University Medical Center, at 1215 Lee St, Charlottesville, VA 22908 in Charlottesville City. The practice phone is (434) 760-3439.

Dr. Payne's primary practice is UVA University Medical Center in Charlottesville, Virginia. Dr. Payne is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Payne to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Payne practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Payne's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Payne is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Payne's licenses on file in 2 states: Virginia and Massachusetts.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis and endoscopic sinus surgery among the conditions Dr. Payne treats.

CMS data shows 838 Medicare services from Dr. Payne across 8 procedure codes in 2024, for 280 Medicare patients. Medicare paid $62,126 for them.

CMS counts 280 Medicare patients who saw Dr. Payne in 2024. The largest group is 65 to 74, with 147 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Payne's median patient age at 55, with 51% women.

In 2024, Dr. Payne wrote 126 Medicare Part D claims for 60 patients. 85% of them were for generic drugs. CMS names the drug for 54 of them, across 4 drugs with 11 or more claims each, at $677 in total drug cost. In 2023, CMS named 56 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Payne for performance year 2024, reported as part of a group. Dr. Payne accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 96 papers to Dr. Payne, published from 2009 to 2024. 2020 was the busiest year, with 11. The most frequent topics are Sinusitis, Rhinitis and Nasal Polyps. Dr. Payne has published most often in Int Forum Allergy Rhinol. Dr. Payne's most frequent co-authors are Zachary Michael Soler, MD, Philip Ga-Houng Chen, MD and Richard Rosenfeld, MD.

Dmand AI links Dr. Payne to 4 clinical trials. Conditions studied include Asthma, Aspirin-Induced, Nasal Polyps and Sinusitis.

CMS Open Payments shows 127 general payments to Dr. Payne from 14 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 58% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $36,864.

Dmand AI lists 5 awards for Dr. Payne, most recently Best Doctor Awards in 2018.

Dr. Payne graduated from Renaissance School of Medicine at Stony Brook University in 2001. Dr. Payne is a member of American Academy of Otololaryngology (AAO) - Head & Neck Surgery HNS and American Rhinologic Society.

Dr. Payne is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.